PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
PALB2 mutations confer a 14% risk of breast cancer by age 50 and a 35% risk by age 70, similar to BRCA2. http://t.co/uEOYvWMjNK
Loss-of-function mutations in PALB2, a BRCA partner -> risk of breast #cancer http://t.co/MXJS6MY8Ro @NEJM #genomics http://t.co/EHq5pRza9D
Loss-of-function mutations in PALB2, a BRCA partner -> risk of breast #cancer http://t.co/MXJS6MY8Ro @NEJM #genomics http://t.co/EHq5pRza9D